UK Held Back By ‘Painfully Slow’ NHS Decision-Making, Uncompetitive Drug Pricing
Executive Summary
A panel of experts has outlined several areas for improvement in the UK’s life sciences ecosystem in light of a report by Sanofi that supports claims that the UK is lagging behind EU competitors in its delivery of innovative medicines to patients.